Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211659) titled 'Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Theolytics Limited
Condition:
Ovarian Cancer
Intervention:
Biological: THEO-260
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 2025
Target Sample Size: 18
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07211659
Published by HT Digital Content Serv...